Wednesday, July 8, 2026

biotech · Sleep · T-Cell Acute Lymphoblastic Leukemia/Lymphoma · BEAM

Beam Therapeutics

News and analysis for Beam Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

Cambridge, USA HQ
2017 Founded
573 Employees
Public company Type
BEAM · NYSE Ticker
Company details
Status
Public
HQ
Cambridge, USA
Founded
2017
Employees
573
Programs
10
Drugs
14
Patents
14
Intelligence · Coverage

News & analysis

NovaPharmaNews articles mentioning Beam Therapeutics — regulatory, clinical, and market coverage.

News and analysis for Beam Therapeutics on NovaPharmaNews — regulatory, clinical, and market coverage.

No coverage yet

We have not published news or analysis mentioning Beam Therapeutics yet.

Back to company overview →